PharmiWeb.com - Global Pharma News & Resources
15-Dec-2021

Cancer Profiling Market to Expand at a Healthy CAGR of 17.7% through 2031

The global cancer profiling market is expected to yield significant gains across 2021, as preference for precision-based medicine and high quality oncology care acquires increasing traction. With global cancer burden slated to proliferate, patients and medical practitioners alike are scrambling to offer highly efficacious and long-lasting cancer diagnostics, prompting the entry of numerous service providers.

Increasing prevalence of diseases across the globe is generating huge demand for advanced healthcare system. As a result, more and more technologically advanced medical devices are being employed to aid medical Practitioners and professionals in medical setups. Sales of Cancer Profiling devices are soaring rapidly.

The Market survey of Cancer Profiling offers a comprehensive analysis of diverse features, including production capacities analysis of Cancer Profiling, demand, product developments, revenue generation, and Size of Cancer Profiling Market across the globe.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-https://www.factmr.com/connectus/sample?flag=S&rep_id=358

Cancer Profiling Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Cancer Profiling insightful data for the specific country/regions.

Key Market Segments Covered

  • Product
    • Instruments
      • Immunohistochemistry (IHC) Analyzers
      • Fluorescence in-situ Hybridization (FISH) Instruments
      • PCR Instruments
      • DNA Sequencer
      • Fragment Analyzer
    • Consumables
      • Reagents & Kits
      • Other Ancillary (Probes, Holders, etc.)
  • Indication
    • Breast Cancer
    • Colorectal Cancer
    • Ovarian Cancer
    • Melanoma
    • Kidney Cancer
    • Lung Cancer (including NSCLC)
    • Rare Cancers
  • End User
    • Hospitals
    • Diagnostic Centers
    • Cancer Research Institutes
    • Others
  • Test
    • Immunohistochemistry (IHC)
    • Fluorescence in-situ Hybridization (FISH)
    • Qualitative Polymerase Chain Reaction (qPCR)
    • Next Generation Sequencing (NGS)
    • Sanger Testing
    • Fragment Analysis
  • Region
    • North America
    • Latin America
    • Europe
    • CIS & Russia
    • Japan
    • APEJ
    • MEA

Need More information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=358

Report Benefits & Key Questions Answered

  • Cancer Profiling Category and segment level analysis: Fact MR offers detailed analysis of the factors influencing the sales prospect across key segments. Cancer Profiling category analysis provides deep insights into customer experiences, emerging trends and growth drivers. The vital information highlighted in this section will enable market players to make timely business decision to gain competitive advantage.
  • Cancer Profiling Manufacturing trend analysis: A key aspect of the study is comprehensive Cancer Profiling manufacturing trend analysis. These insights provide vital information on how market players are coping with latest trends that are prevailing in the market.
  • Innovation and acquisition activity in Cancer Profiling: The report highlights in detail the various organic and inorganic strategies adopted manufacturers in order to gain a competitive edge in Cancer Profiling market. Adoption of various technologies are being discussed in detail.
  • Cancer Profiling demand by country: The report forecasts the country wise demand for Cancer Profiling between 2021 and 2031. By analyzing this section of the report, Cancer Profiling manufacturers can accordingly invest in those regions where the demand is on the rise.
  • Post COVID consumer spending on Cancer Profiling: The Fact.MR market survey also highlights the impact of COVID-19 on medical devices industry. These insights provide vital information on how market players are executing their manufacturing strategies to coup with the COVID-19 pandemic.

 

Some Notable Offerings by Fact.MR Report on Cancer Profiling market:

  • MR will provide you an analysis of the extent to which this Cancer Profiling market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
  • MR will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
  • Also, this report will help you to identify any trends to forecast growth rates.
  • The analyzed report will forecast the general tendency for supply and demand.

To get all-in insights on the regional landscape of the Cancer Profiling Market, Buy Now:-https://www.factmr.com/checkout/358

Competitive Landscape

These aforementioned players rely on a variety of organic and inorganic growth strategies to cement their market presence. Offering new products, forging strategic alliances, acquisitions and mergers with other players, and conducting clinical trials for determining drug efficacy are a few examples.

  • For instance, F. Hoffmann La Roche Ltd. presented updated overall survival (OS) data from its Phase III IMbrave 150 study evaluating Tecentriq® (atezolizumab) in combination with Avastin® (bevazicumab) in comparison with sorafenib in people suffering from unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy.
  • In January 2021, Illumina Inc. announced a series of new and expanded oncology partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck, to advance comprehensive genomic profiling. These partnerships were concluded to expand its TruSightTM Oncology 500 (TSO 500) Research Use Only comprehensive pan-cancer assay to profile known and emerging biotumors.
  • Recently, February 2021, QIAGEN NV partnered with INOVIO to develop next generation sequencing (NGS) companion diagnostics for the latter’s VGX-3100 for cervical dysplasia treatment. The initial project in this expanded collaboration focuses on the co-development of a diagnostic test that identifies women who are most likely to benefit from clinical use of VGX-3100.

After reading the Market insights of Cancer Profiling Report, readers can:

  • Understand the drivers, restraints, opportunities and trends affecting the Sales of market.
  • Analyze key regions holding significant share of total Cancer Profiling market revenue.
  • Study the growth outlook of Cancer Profiling market scenario, including production, consumption, history and forecast.
  • Learn consumption pattern and impact of each end use & supply side analysis of Cancer Profiling market.
  • Investigate the recent R&D projects performed by each market player & competitive analysis of Cancer Profiling Market Players.

Read More Trending Reports of Fact.MR: – https://www.biospace.com/article/breast-cancer-diagnostics-market-sales-set-to-grow-by-4-7-percent-to-surpass-us-2000-mn-by-2022-end-fact-mr

How Fact.MR Assists in Making Strategic Moves For Cancer Profiling Market Manufacturer?

  • The data provided in the Cancer Profiling market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
  • The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.

 

More Related Reports by Fact.MR on Healthcare Sector: 

Sterile Compounding Pharmacies Market :-_ Sterile Compounding Pharmacies Market Growth to Spur with Rising Demand for Injectables during 2021-2031

Testosterone Nasal Gels Market:- Testosterone Nasal Gels Market Share Analysis By Indication, By Dosage (5mg, 10mg), By Distribution Channel & By Region Forecast, 2021-2031

Wireless Handheld Ultrasound Devices Market:- Small Size and Easy to Operate Functions to Boost the Sales of Wireless Handheld Ultrasound Devices during 2021-2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

 

The post Cancer Profiling Market to Expand at a Healthy CAGR of 17.7% through 2031 appeared first on Latest Market Reports.

Editor Details

Last Updated: 15-Dec-2021